Détail de l'auteur
Auteur L. DEGENHARDT |
Documents disponibles écrits par cet auteur (103)
Livre
Chapitre
Cannabis is the illicit drug that is most often used by adolescents and the one that young people are most likely to develop dependence on. Cannabis dependence is more common in males, especially those who display disruptive and antisocial behav[...]Périodique
W. HALL ; L. DEGENHARDT | 2009ENGLISH : For over two decades, cannabis, commonly known as marijuana, has been the most widely used illicit drug by young people in high-income countries, and has recently become popular on a global scale. Epidemiological research during the [...]Périodique
Age differentials in the impacts of reduced heroin: Effects of a "heroin shortage" in NSW, Australia
L. DEGENHARDT ; C. DAY ; CONROY E. ; S. GILMOUR ; W. HALL | 2005ENGLISH : Background: This paper uses a unique event, the Australian heroin shortage, to see whether an abrupt, substantial and sustained change in heroin supply had different effects on harms related to heroin use among younger and older hero[...]Article : Périodique
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT |BACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]Périodique
L. DEGENHARDT ; W. HALL ; M. LYNSKEY | 2001ENGLISH : Aim. To compare relationships between alcohol, cannabis and tobacco and indicators of mental health problems in the general population. Method. A survey of a nationally representative sample of 10 641 Australian adults (the National [...]Périodique
C. BREEN ; L. DEGENHARDT ; S. KINNER ; R. BRUNO ; R. JENKINSON ; A. MATTHEWS ; J. NEWMAN | 2006ENGLISH : We examine alcohol use in conjunction with ecstasy use and risk-taking behaviors among regular ecstasy users in every capital city in Australia. Data on drug use and risks were collected in 2004 from a national sample of 852 regular [...]Article : Périodique
The Eleventh Revision of the International Classification of Diseases (ICD-11) was formally published in May 2019. Alcohol use disorders form a key part of the section of Disorders due to Substance Use and Addictive Behaviours. This review descr[...]Article : Périodique
A. PEACOCK ; L. T. TRAN ; S. LARNEY ; E. STOCKINGS ; T. SANTO ; H. JONES ; D. SANTOMAURO ; L. DEGENHARDT |AIMS: To estimate pooled all-cause and cause-specific mortality risk for people with regular or problematic cocaine use. METHODS: Systematic review and meta-analysis of prospective or retrospective cohort studies or clinical trials (n > = 30) o[...]Périodique
J. McGRATH ; J. WELHAM ; J. SCOTT ; D. VARGHESE ; L. DEGENHARDT ; M. R. HAYATBAKHSH ; R. ALATI ; G. M. WILLIAMS ; W. BOR ; J. M. NAJMAN | 2010Context: Prospective cohort studies have identified an association between cannabis use and later psychosis-related outcomes, but concerns remain about unmeasured confounding variables. The use of sibling pair analysis reduces the influence of u[...]Article : Périodique
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY |BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]Rapport
A. PEACOCK ; J. UPOROVA ; A. KARLSSON ; O. PRICE ; D. GIBBS ; R. SWANTON ; R. CHAN ; R. BRUNO ; P. DIETZE ; S. LENTON ; C. SALOM ; L. DEGENHARDT ; M. FARRELL | Sydney : National Drug and Alcohol Research Centre, University of New South Wales | 2021The Illicit Drug Reporting System (IDRS) is a national illicit drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets, and forms part of Drug Trends. The IDRS consists of annual intervie[...]Rapport
M. DUNN ; L. DEGENHARDT ; G. CAMPBELL ; J. GEORGE ; J. JOHNSTON ; S. KINNER ; A. MATTHEWS ; J. NEWMAN ; N. WHITE | Sydney : NDARC (National Drug and Alcohol Research Centre) | 2007The Australian Drug Trends 2006 report presents the findings from the fourth year in which data has been collected in all states and territories in Australia on the markets for ecstasy and related drugs. The Ecstasy and Related Drugs Reporting S[...]Article : Périodique
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL |Background: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]Article : Périodique
N. BLACK ; E. STOCKINGS ; G. CAMPBELL ; L. T. TRAN ; D. ZAGIC ; W. D. HALL ; M. FARRELL ; L. DEGENHARDT |Background: Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain[...]Article : Périodique
W. SWIFT ; C. COFFEY ; L. DEGENHARDT ; J. B. CARLIN ; H. ROMANIUK ; G. C. PATTON |Background: Adolescent cannabis use predicts the onset of later illicit drug use. In contrast, little is known about whether cannabis in young adulthood also predicts subsequent progression or cessation of licit or illicit drug use. Methods: 1[...]Périodique
COFFREY C. ; J. B. CARLIN ; L. DEGENHARDT ; M. LYNSKEY ; SANCI L. ; G. C. PATTON | 2002FRANÇAIS : Dans une population représentative de 1601 jeunes adultes en 1998, l'usage de cannabis, les symptômes de dépendance et la différence de symptomatologie entre les syndromes alcoolique et cannabique sont étudiés. 59% rapportent une con[...]Périodique
G. C. PATTON ; C. COFFEY ; J. B. CARLIN ; L. DEGENHARDT ; M. LYNSKEY ; W. HALL | 2002ENGLISH : Objective. To determine whether cannabis use in adolescence predisposes to higher rates of depression and anxiety in young adulthood. Design. Seven wave cohort study over six years. Setting. 44 schools in the Australian state of Vict[...]Article : Périodique
L. DEGENHARDT ; S. LARNEY ; D. RANDALL ; L. BURNS ; W. HALL |Aims: To examine changes in causes of death in a cohort treated for opioid dependence, across time and age; quantify years of potential life lost (YPLL); and identify avoidable causes of death. Design: People in New South Wales (NSW) who regist[...]Périodique
A. ROXBURGH ; L. DEGENHARDT ; C. BREEN | 2004ENGLISH : The aim of this study was to examine changes in drug use patterns among groups of injecting drug users (IDU) who remained in the drug market during a period of reduced heroin availability in NSW, Australia. Cross-sectional data colle[...]Article : Périodique
L. SORDO ; B. I. INDAVE ; G. BARRIO ; L. DEGENHARDT ; L. DE LA FUENTE ; M. J. BRAVO |Background: Both cocaine use and strokes impact public health. Cocaine is a putative cause of strokes, but no systematic review of the scientific evidence has been published. Methods: All relevant bibliographic-databases were searched until Ja[...]Périodique
J. H. JAFFE ; M. GOSSOP ; M. TYNDALL ; R. E. MANN ; P. REUTER ; W. HAO ; D. WEATHERBURN ; J. P. CAULKINS ; L. DEGENHARDT ; W. HALL ; C. DAY ; P. DIETZE ; L. COLLINS ; POINTER S. | 2005Neuf commentaires sont proposés. Le premier, au regard des résultats de cette étude analyse un événement similaire survenu aux Etats-Unis en 1972/1973. Le deuxième s'intéresse aux conséquences du transfert de l'usage injectable d'héroïne vers l'[...]Article : Périodique
S. NIELSEN ; N. MENON ; S. LARNEY ; M. FARRELL ; L. DEGENHARDT |Aim: Given the potential to expand naloxone supply through community pharmacy, the aim of this study was to estimate Australian pharmacists': (1) level of support for overdose prevention, (2) barriers and facilitators for naloxone supply and (3)[...]Rapport
L. DEGENHARDT ; C. HALLAM ; D. R. BEWLEY-TAYLOR | Oxford : The Beckley Foundation Drug Policy Programme | Briefing Paper | 2009This paper seeks to compare the drugs situation in a number of developed countries. Data from eight indicators are for the first time compared across six European countries (Denmark, Germany, The Netherlands, Portugal, Sweden, the United Kingdom[...]Article : Périodique
L. DEGENHARDT ; C. BHARAT ; R. BRUNO ; M. D. GLANTZ ; N. A. SAMPSON ; L. LAGO ; S. AGUILAR-GAXIOLA ; J. ALONSO ; L. H. ANDRADE ; B. BUNTING ; J. M. CALDAS-DE-ALMEIDA ; A. H. CIA ; O. GUREJE ; E. G. KARAM ; M. KHALAF ; J. J. MCGRATH ; J. MOSKALEWICZ ; S. LEE ; Z. MNEIMNEH ; F. NAVARRO-MATEU ; C. C. SASU ; K. SCOTT ; Y. TORRES ; V. POZNYAK ; S. CHATTERJI ; R. C. KESSLER ; WHO World Mental Health Survey Collaborators |BACKGROUND AND AIMS: The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consi[...]Article : Périodique
M. G. HARRIS ; C. BHARAT ; M. D. GLANTZ ; N. A. SAMPSON ; A. AL-HAMZAWI ; J. ALONSO ; R. BRUFFAERTS ; J. M. CALDAS DE ALMEIDA ; A. H. CIA ; G. DE GIROLAMO ; S. FLORESCU ; O. GUREJE ; J. M. HARO ; H. HINKOV ; E. G. KARAM ; G. KARAM ; S. LEE ; J. P. LEPINE ; D. LEVINSON ; V. MAKANJUOLA ; J. McGRATH ; Z. MNEIMNEH ; F. NAVARRO-MATEU ; M. PIAZZA ; J. POSADA-VILLA ; C. RAPSEY ; H. TACHIMORI ; M. TEN HAVE ; Y. TORRES ; M. C. VIANA ; S. CHATTERJI ; A. M. ZASLAVSKY ; R. C. KESSLER ; L. DEGENHARDT ; WHO World Mental Health Survey Collaborators |AIMS: To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. DESIGN: Cross-sectional, representative household surveys. [...]Article : Périodique
S. LARNEY ; J. GREBELY ; M. HICKMAN ; D. DE ANGELIS ; G. J. DORE ; L. DEGENHARDT |There is considerable interest in determining the impact that increased uptake of treatment for hepatitis C virus (HCV) infection will have on the burden of HCV among people who inject drugs (PWID). An understanding of the size of the population[...]Article : Périodique
B. LARANCE ; L. DEGENHARDT ; N. LINTZERIS ; A. WINSTOCK ; R. MATTICK |AIMS: This paper (i) reviews the language used to describe and manage those patient practices that fall outside standard medical models of opioid treatment (for pain and opioid dependence), and (ii) proposes a consistent terminology that can be [...]Article : Périodique
L. DEGENHARDT ; M. LYNSKEY ; C. COFFEY ; G. PATTON |Objective: To examine the characteristics of 'diagnostic orphans' among cannabis users - those who report one or two symptoms of DSM-IV dependence but do not meet diagnostic criteria for DSM-IV abuse or dependence. Method: Data were collected fr[...]Article : Périodique
B. CALABRIA ; L. DEGENHARDT ; W. HALL ; M. LYNSKEY |ISSUES: To conduct a comprehensive search of the peer-reviewed literature to assess risk of cannabis-related mortality. APPROACH: Systematic peer-reviewed literature searches were conducted in Medline, EMBASE and PsycINFO to identify data on mor[...]Article : Périodique
L. DEGENHARDT ; H. ROMANIUK ; C. COFFEY ; W. D. HALL ; W. SWIFT ; J. B. CARLIN ; C. O'LOUGHLIN ; G. C. PATTON |BACKGROUND: There are limited longitudinal data on the associations between different social contexts of alcohol use and risky adolescent drinking. METHODS: Australian prospective longitudinal cohort of 1943 adolescents with 6 assessment waves [...]Article : Périodique
ENGLISH : Background: This paper examines the differences in demographics, drug use patterns and self reported risk behaviours between regular injecting drug users (IDU) who report engaging in sex work for money or drugs and regular injecting [...]Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Périodique
C. DAY ; L. DEGENHARDT ; S. GILMOUR ; W. HALL | 2004ENGLISH : We found a sustained reduction in the number of needles and syringes distributed in NSW [New South Wales] after a considerable decrease in heroin supply. Given the widespread and easy availability of needles and syringes in NSW, the [...]Périodique
C. DAY ; L. DEGENHARDT ; S. GILMOUR ; W. HALL | 2004ENGLISH : In early 2001 there was a dramatic decline in the availability of heroin in New South Vales (NSW), Australia, where previously heroin had been readily available at a low price and high purity. The decline was confirmed by Australia's[...]Périodique
L. DEGENHARDT ; C. DAY ; P. DIETZE ; POINTER S. ; CONROY E. ; L. COLLINS ; W. HALL | 2005ENGLISH : Background: In early 2001 in Australia there was a sudden and dramatic decrease in heroin availability that occurred throughout the country that was evidenced by marked increases in heroin price and decreases in its purity. Aim: This[...]Article : Périodique
L. DEGENHARDT ; N. GISEV ; J. TREVENA ; S. LARNEY ; J. KIMBER ; L. BURNS ; M. SHANAHAN ; D. WEATHERBURN |Aims: Studies of offending among people who use drugs typically focus upon small and potentially unrepresentative samples. We examined an entire population of opioid-dependent clients' contact with the criminal justice system to develop more acc[...]Article : Périodique
L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY |BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]Article : Périodique
S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT |Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]Périodique
M. HICKMAN ; C. TAYLOR ; A. CHATTERJEE ; L. DEGENHARDT ; M. FRISCHER ; G. HAY ; K. TILLING ; L. WIESSING ; P. GRIFFITHS ; R. McKETIN | 2002Les décideurs ont de plus en plus besoin d'estimations de la prévalence de la consommation problématique de drogues, comme l'usage par voie intraveineuse et la consommation de "crack". Dans cet article, les auteurs passent en revue les méthodes [...]Périodique
L. DEGENHARDT ; P. REUTER ; L. COLLINS ; W. HALL | 2005FRANÇAIS : En 2001, une pénurie abrupte en héroïne est survenue en Australie, alors qu'aucun des autres pays s'approvisionnant sur les mêmes marchés ne signalait un tel phénomène. L'hypothèse proposée est la combinaison de plusieurs facteurs a[...]Article : Périodique
L. DEGENHARDT ; S. LARNEY ; J. KIMBER ; M. FARRELL ; W. HALL |Introduction and Aims: To estimate the number of deaths that would have occurred among patients receiving oral naltrexone for opioid use under the Special Access Scheme if these patients had received methadone. Design and Methods: We analysed [...]Article : Périodique
FRANÇAIS : Le lien entre cannabis et dépression a été exploré à partir d'une revue des recherches scientifiques indexées dans les bases de données Medline, Psychinfo et Embase. Les conclusions montrent que seul un usage lourd de cannabis peut [...]Article : Périodique
FRANÇAIS : L'article recense les résultats des études concernant la fréquence, les effets corrélés et les conséquences probables pour la santé publique de la consommation d'amphétamines, de cannabis, de cocaïne et d'opiacés. Les auteurs font[...]Article : Périodique
Introduction and Aims: To investigate the predictors of both initiation of cannabis use and transition to cannabis use disorder (CUD) in a nationally representative sample using discrete-time survival analyses. Design and Methods: Data from a [...]Article : Périodique
D. LEWER ; J. FREER ; E. KING ; S. LARNEY ; L. DEGENHARDT ; E. J. TWEED ; V. D. HOPE ; M. HARRIS ; T. MILLAR ; A. HAYWARD ; D. CICCARONE ; K. I. MORLEY |AIMS: To summarize evidence on the frequency and predictors of health-care utilization among people who use illicit drugs. DESIGN: Systematic search of MEDLINE, EMBASE and PsychINFO for observational studies reporting health-care utilization pub[...]Article : Périodique
S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT |BACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]Article : Périodique
L. DEGENHARDT ; H. A. WHITEFORD ; A. J. FERRARI ; A. J. BAXTER ; F. J. CHARLSON ; W. D. HALL ; G. FREEDMAN ; R. BURSTEIN ; N. JOHNS ; R. E. ENGELL ; A. D. FLAXMAN ; C. J. L. MURRAY ; T. VOS |BACKGROUND: No systematic attempts have been made to estimate the global and regional prevalence of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their burden. We aimed to assess the prevalence and burden of drug dependence[...]Article : Périodique
H. A. WHITEFORD ; L. DEGENHARDT ; J. REHM ; A. J. BAXTER ; A. J. FERRARI ; H. E. ERSKINE ; F. J. CHARLSON ; R. E. NORMAN ; A. D. FLAXMAN ; N. JOHNS ; R. BURSTEIN ; C. J. L. MURRAY ; T. VOS |BACKGROUND: We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and substance use disorders in terms of disability-adjusted life years (DALYs)[...]Article : Périodique
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT |BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]Article : Périodique
P. K. NELSON ; B. M. MATHERS ; B. COWIE ; H. HAGAN ; D. C. DES JARLAIS ; D. HORYNIAK ; L. DEGENHARDT |BACKGROUND: Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population siz[...]Périodique
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008ENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Article : Périodique
J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY |BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]Article : Périodique
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY |We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]Article : Périodique
L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY |Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]Article : Périodique
S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT |Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]Article : Périodique
J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT |BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]Article : Périodique
A. PEACOCK ; J. LEUNG ; S. LARNEY ; S. COLLEDGE ; M. HICKMAN ; J. REHM ; G. A. GIOVINO ; R. WEST ; W. HALL ; P. GRIFFITHS ; R. ALI ; L. GOWING ; J. MARSDEN ; A. J. FERRARI ; J. GREBELY ; M. FARRELL ; L. DEGENHARDT |AIMS: This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addresse[...]Article : Périodique
G. C. PATTON ; C. COFFEY ; C. CAPPA ; D. CURRIE ; L. RILEY ; F. GORE ; L. DEGENHARDT ; D. RICHARDSON ; N. M. ASTONE ; A. O. SANGOWAWA ; A. MOKDAD ; J. FERGUSON |Adolescence and young adulthood offer opportunities for health gains both through prevention and early clinical intervention. Yet development of health information systems to support this work has been weak and so far lagged behind those for ear[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; H. ALI ; L. WIESSING ; M. HICKMAN ; R. P. MATTICK ; B. MYERS ; A. AMBEKAR ; S. A. STRATHDEE ; Reference Group to the UN on HIV and Injecting Drug Use |Background: Previous reviews have examined the existence of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide, but they did not quantify the scale of coverage. We undertook a systematic review to estimate nat[...]Article : Périodique
D. HORYNIAK ; M. STOOVE ; L. DEGENHARDT ; C. AITKEN ; T. KERR ; P. DIETZE |Background: Changes in drug market characteristics have been shown to affect drug use patterns but few studies have examined their impacts on injecting initiation experiences and subsequent patterns of injecting drug use (IDU). Methods: We coll[...]Article : Périodique
BACKGROUND: In early 2001 Australia experienced a sudden reduction in the availability of heroin which had widespread effects on illicit drug markets across the country. The consequences of this event, commonly referred to as the Australian 'her[...]Article : Périodique
L. T. TRAN ; A. PEACOCK ; S. COLLEDGE ; S. MEMEDOVIC ; J. GREBELY ; J. LEUNG ; S. LARNEY ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; M. HICKMAN ; L. DEGENHARDT |Background: Injecting risk behaviour, such as receptive sharing of injecting equipment and/or re-using one's equipment, is associated with bloodborne virus transmission and infections in people who inject drugs (PWID). We aimed to estimate preva[...]Article : Périodique
E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY |Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]Article : Périodique
FRANÇAIS : Objectif : Évaluer si l'usage du cannabis à l'adolescence et au jeune âge adulte est une cause concourante de la psychose schizophréniforme, en ce qu'il peut précipiter la psychose chez les personnes vulnérables. Méthode : Nous avo[...]Périodique
M. T. LYNSKEY ; C. COFFEY ; L. DEGENHARDT ; J. B. CARLIN ; G. PATTON | 2003FRANÇAIS : Cette étude prospective australienne en population générale auprès de 1601 adolescents âgés de 15 à 21 ans a collecté par questionnaire des données sur la consommation hebdomadaire de cannabis et sur le cursus scolaire, notamment sur[...]Article : Périodique
Article : Périodique
FRANÇAIS : Commentaires généraux à partir des résultats du rapport de Hickman et al. (2003, Royaume-Uni - cf. pp.419-425) sur l'évolution des décès liés à la méthadone ou à l'héroïne, sur l'accès au traitement et les risques d'overdoses.Article : Périodique
L. DEGENHARDT ; J. SINGLETON ; B. CALABRIA ; J. MCLAREN ; T. KERR ; S. MEHTA ; G. KIRK ; W. D. HALL |Aims To conduct a systematic review of mortality among cohort studies of cocaine users. Methods Three electronic databases were searched (EMBASE, Medline and PsychINFO); other online databases were searched using online libraries and repositori[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; C. BUCELLO ; J. LEMON ; L. WIESSING ; M. HICKMAN |FRANÇAIS : Objectif : Examiner systématiquement les études de cohortes de la mortalité chez les toxicomanes par injection, étudier les taux de mortalité et les causes de décès dans ce groupe, et identifier les variables, au niveau des participa[...]Article : Périodique
L. DEGENHARDT ; C. BUCELLO ; B. MATHERS ; C. BRIEGLEB ; H. ALI ; M. HICKMAN ; J. MCLAREN |AIMS: To review the literature on mortality among dependent or regular users of opioids across regions, according to specific causes, and related to a number of demographic and clinical variables. METHODS: Multiple search strategies included sea[...]Livre
S. DARKE ; L. DEGENHARDT ; R. MATTICK | Cambridge - New York : Cambridge University Press | International Research Monographs in the Addictions (IRMA) | 2006ENGLISH : Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are the clinical, ethical and psychopathological implications of these[...]Article : Périodique
L. SORDO ; G. BARRIO ; M. J. BRAVO ; B. I. INDAVE ; L. DEGENHARDT ; L. WIESSING ; M. FERRI ; R. PASTOR-BARRIUSO |Objective: To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and ces[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
A. PEACOCK ; R. BRUNO ; N. GISEV ; L. DEGENHARDT ; W. HALL ; R. SEDEFOV ; J. WHITE ; K. V. THOMAS ; M. FARRELL ; P. GRIFFITHS |The rapid emergence since the mid-2000s of a large and diverse range of substances originally designed as legal alternatives to more established illicit drugs (pragmatically clustered and termed new psychoactive substances; [NPS]) has challenged[...]Article : Périodique
G. J. MACARTHUR ; S. MINOZZI ; N. MARTIN ; P. VICKERMAN ; S. DEREN ; J. BRUNEAU ; L. DEGENHARDT ; M. HICKMAN |Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data [...]Article : Périodique
S. LARNEY ; N. GISEV ; M. FARRELL ; T. A. DOBBINS ; L. BURNS ; A. GIBSON ; J. KIMBER ; L. DEGENHARDT |Objectives: To describe deaths in prison among opioid-dependent people, and examine associations between receipt of opioid substitution therapy (OST) and risk of death in prison. Design: Retrospective cohort study. Setting: Adult prisons in Ne[...]Périodique
L. DEGENHARDT ; W. HALL | 2003ENGLISH : The present study describes patterns of co-morbidity between alcohol use and other substance use problems in the Australian population using data from the 1997 National Survey of Mental Health and Well-Being. Multiple regression anal[...]Périodique
L. DEGENHARDT ; B. BARKER ; L. TOPP | 2004FRANÇAIS : En 2001, 6,1% des Australiens âgés de 14 ans et plus rapportent au moins un usage d'ecstasy au cours de leur vie, et 2,9% un usage récent. 10% des 20-29 ans et 5% des 14-19 ans ont consommé récemment de l'ecstasy. La principale carac[...]Article : Périodique
Aims: A systematic review and meta-analysis were conducted to synthesize results from cohort studies on initiation into drug injection among vulnerable populations, to quantify heterogeneity in the estimated incidence rates of drug injection and[...]Article : Périodique
ENGLISH : PURPOSE OF REVIEW: The aim of this article is to review recent research on the prevalence, antecedents and correlates of cannabis use in young adults in developed and developing countries. RECENT FINDINGS: Cannabis is the most widely[...]Article : Périodique
E. STOCKINGS ; W. D. HALL ; M. LYNSKEY ; K. I. MORLEY ; N. REAVLEY ; J. STRANG ; G. PATTON ; L. DEGENHARDT |We did a systematic review of reviews with evidence on the effectiveness of prevention, early intervention, harm reduction, and treatment of problem use in young people for tobacco, alcohol, and illicit drugs (eg, cannabis, opioids, amphetamines[...]Article : Périodique
L. DEGENHARDT ; B. MATHERS ; P. VICKERMAN ; T. RHODES ; C. LATKIN ; M. HICKMAN |HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individu[...]Article : Périodique
W. HALL ; D. STJEPANOVIC ; J. CAULKINS ; M. LYNSKEY ; J. LEUNG ; G. CAMPBELL ; L. DEGENHARDT |We assess the current and describe possible future public health impacts of the legalisation of cannabis production, sale, and use in the Americas. First, we describe global patterns of cannabis use and their most probable adverse health effects[...]Périodique
L. DEGENHARDT ; L. TOPP ; C. DAY | 2003FRANÇAIS : Dans le présent article, les auteurs traitent de la difficulté de cerner et de démontrer les changements affectant la disponibilité ou l'offre de drogues sur le marché. Ils distinguent entre l'offre et la demande (ou consommation), l[...]Article : Périodique
E. ZAHRA ; S. DARKE ; L. DEGENHARDT ; G. CAMPBELL |Background: The most commonly used illicit substance worldwide is cannabis. To date, no national level study of cannabis-related death has been undertaken in Australia. The current study aimed to investigate the rates, characteristics and manner[...]Périodique
A. GIBSON ; L. DEGENHARDT ; C. DAY ; R. McKETIN | 2005ENGLISH : Heroin causes its users and the community a disproportionate amount of harm, and evidence suggests that heroin markets have increased in scale over recent decades. Most of the world's heroin is produced in South West (SW) Asia (Afgha[...]Article : Périodique
ENGLISH : The use of "club drugs" such as MDMA, ketamine, and GHB appears to have increased in Western countries over the last 20 years, and Australia is no exception to that trend. While levels of use appear to be relatively low in the genera[...]Article : Périodique
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users |Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]NouveautéArticle : Périodique
M. FARRELL ; N. K. MARTIN ; E. STOCKINGS ; A. BORQUEZ ; J. A. CEPEDA ; L. DEGENHARDT ; R. ALI ; L. T. TRAN ; J. REHM ; M. TORRENS ; S. SHOPTAW ; R. McKETIN |We did a global review to synthesise data on the prevalence, harms, and interventions for stimulant use, focusing specifically on the use of cocaine and amphetamines. Modelling estimated the effect of cocaine and amphetamine use on mortality, su[...]Périodique
B. WHITE ; L. DEGENHARDT ; C. BREEN ; R. BRUNO ; J. NEWMAN ; P. PROUDFOOT | 2006ENGLISH : A cross-sectional survey of 372 regular ecstasy users was conducted to examine the benefits and risks perceived to be associated with the use of party drugs. A wide range of benefits and risks were reported across six drug types with[...]Article : Périodique
F. L. SHAND ; L. DEGENHARDT ; T. SLADE ; E. C. NELSON |Introduction and aims To examine differences in the characteristics and histories of male and female dependent heroin users, and in the clinical characteristics associated with multiple substance dependence diagnoses. Design and methods 1513 h[...]Article : Périodique
L. DEGENHARDT ; D. WOLFE ; W. HALL ; M. HICKMAN ; J. CHANG ; J. BRUNEAU ; M. FARRELL ; P. GRIFFITHS |The 1961 UN Single Convention on Narcotic Drugs proposed to end all non-medical use of cannabis, coca, opium poppy, and their derivatives. In the nearly 60 years since then, global drug use and harm have increased despite better scientific under[...]Périodique
M. TEESSON ; U. DIETRICH ; L. DEGENHARDT ; M. LYNSKEY ; J. BEARD | 2002ENGLISH : A community survey of the common mental disorders in a geographically defined treatment service area was used to explore the socio-demographic correlates and service utilization of people with alcohol and drug use disorders living in[...]Article : Périodique
S. LARNEY ; A. PEACOCK ; B. M. MATHERS ; M. HICKMAN ; L. DEGENHARDT |Background: Non-viral injecting-related injuries and diseases (IRID), such as abscesses and vascular damage, can result in significant morbidity and mortality if untreated. There has been no systematic assessment of the prevalence of non-viral I[...]Article : Périodique
B. CALABRIA ; L. DEGENHARDT ; C. BRIEGLEB ; T. VOS ; W. HALL ; M. LYNSKEY ; B. CALLAGHAN ; U. RANA ; J. MCLAREN |AIMS: To review and summarize existing prospective studies reporting on remission from dependence upon amphetamines, cannabis, cocaine or opioids. METHODS: Systematic searches of the peer-reviewed literature were conducted to identify prospecti[...]Périodique
W. HALL ; M. TEESSON ; M. LYNSKEY ; L. DEGENHARDT | 1999FRANÇAIS : Objectifs : estimer la prévalence d'usage de drogues et des troubles liés à cet usage selon l'ICD dans la population d'adultes australiens en utilisant les données de la NSMHWB (Enquête Nationale de Santé Mentale et du Bien-être). Et[...]Article : Périodique
This paper summarizes the most probable of the adverse health effects of regular cannabis use sustained over years, as indicated by epidemiological studies that have established an association between cannabis use and adverse outcomes; ruled out[...]Article : Périodique
L. DEGENHARDT ; S. SAHA ; C. C. W. LIM ; S. AGUILAR-GAXIOLA ; A. AL-HAMZAWI ; J. ALONSO ; L. H. ANDRADE ; E. J. BROMET ; R. BRUFFAERTS ; J. M. CALDAS-DE-ALMEIDA ; G. DE GIROLAMO ; S. FLORESCU ; O. GUREJE ; J. M. HARO ; E. G. KARAM ; G. KARAM ; V. KOVESS-MASFETY ; S. LEE ; J. P. LEPINE ; V. MAKANJUOLA ; M. E. MEDINA-MORA ; Z. MNEIMNEH ; F. NAVARRO-MATEU ; M. PIAZZA ; J. POSADA-VILLA ; N. A. SAMPSON ; K. M. SCOTT ; J. C. STAGNARO ; M. TEN HAVE ; K. S. KENDLER ; R. C. KESSLER ; J. J. MCGRATH ; WHO World Mental Health Survey Collaborators |BACKGROUND AND AIMS: Prior research has found bidirectional associations between psychotic experiences (PEs) and selected substance use disorders. We aimed to extend this research by examining the bidirectional association between PEs and variou[...]Article : Périodique
L. DEGENHARDT ; C. BHARAT ; M. D. GLANTZ ; E. J. BROMET ; J. ALONSO ; R. BRUFFAERTS ; B. BUNTING ; G. DE GIROLAMO ; P. DE JONGE ; S. FLORESCU ; O. GUREJE ; J. M. HARO ; M. G. HARRIS ; H. HINKOV ; E. G. KARAM ; G. KARAM ; V. KOVESS-MASFETY ; S. LEE ; V. MAKANJUOLA ; M. E. MEDINA-MORA ; F. NAVARRO-MATEU ; M. PIAZZA ; J. POSADA-VILLA ; K. M. SCOTT ; D. J. STEIN ; H. TACHIMORI ; N. TINTLE ; Y. TORRES ; M. C. VIANA ; R. C. KESSLER ; WHO World Mental Health Survey Collaborators |Aim: Exposure to traumatic events (TEs) is associated with substance use disorders (SUDs). However, most studies focus on a single TE, and are limited to single countries, rather than across countries with variation in economic, social and cultu[...]Article : Périodique
We describe trends in illicit drug use revealed by the Australian Illicit Drug Reporting System (IDRS) between 1996 and 2006. We begin by briefly outlining the rationale, development, and testing of the IDRS, which integrates information from: i[...]Article : Périodique
L. DEGENHARDT ; C. BHARAT ; M. D. GLANTZ ; N. A. SAMPSON ; K. SCOTT ; C. C. W. LIM ; S. AGUILAR-GAXIOLA ; A. AL-HAMZAWI ; J. ALONSO ; L. H. ANDRADE ; E. J. BROMET ; R. BRUFFAERTS ; B. BUNTING ; G. DE GIROLAMO ; O. GUREJE ; J. M. HARO ; M. G. HARRIS ; Y. HE ; P. DE JONGE ; E. G. KARAM ; G. E. KARAM ; A. KIEJNA ; S. LEE ; J. P. LEPINE ; D. LEVINSON ; V. MAKANJUOLA ; M. E. MEDINA-MORA ; Z. MNEIMNEH ; F. NAVARRO-MATEU ; J. POSADA-VILLA ; D. J. STEIN ; H. TACHIMORI ; Y. TORRES ; Z. ZARKOV ; S. CHATTERJI ; R. C. KESSLER |Background: Illicit drug use and associated disease burden are estimated to have increased over the past few decades, but large gaps remain in our knowledge of the extent of use of these drugs, and especially the extent of problem or dependent u[...]